![Combination drugs / Asthma / GlaxoSmithKline / Chronic lower respiratory diseases / Fluticasone/salmeterol / Salmeterol / Formoterol / Budesonide/formoterol / Long-acting beta-adrenoceptor agonist / Pulmonology / Medicine / Respiratory therapy Combination drugs / Asthma / GlaxoSmithKline / Chronic lower respiratory diseases / Fluticasone/salmeterol / Salmeterol / Formoterol / Budesonide/formoterol / Long-acting beta-adrenoceptor agonist / Pulmonology / Medicine / Respiratory therapy](https://www.pdfsearch.io/img/c2b6350865ee8c67f7b8c81624dd18fc.jpg) Combination drugs Asthma GlaxoSmithKline Chronic lower respiratory diseases Fluticasone/salmeterol Salmeterol Formoterol Budesonide/formoterol Long-acting beta-adrenoceptor agonist Pulmonology Medicine Respiratory therapy | | U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may Add to Reading ListSource URL: www.fda.govDownload Document from Source Website File Size: 76,76 KBShare Document on Facebook
|